Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial.

Autor: Ruwaard, J¹ (AUTHOR) j.ruwaard@reade.nl, L' Ami, MJ¹ (AUTHOR), Kneepkens, EL¹ (AUTHOR), Krieckaert, CLM² (AUTHOR), Nurmohamed, MT^1,2 (AUTHOR), Hooijberg, F¹ (AUTHOR), van Kuijk, AWR¹ (AUTHOR), van Denderen, JC¹ (AUTHOR), Burgemeister, L¹ (AUTHOR), Rispens, T³ (AUTHOR), Boers, M^1,2,4 (AUTHOR), Wolbink, GJ^1,3 (AUTHOR)

Publikováno v: Scandinavian Journal of Rheumatology. Mar2023, Vol. 52 Issue 2, p129-136. 8p.

Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab.

Autor: Ruwaard, J¹ (AUTHOR) j.ruwaard@reade.nl, l'Ami, MJ¹ (AUTHOR), Marsman, AF¹ (AUTHOR), Kneepkens, EL¹ (AUTHOR), van Denderen, JC¹ (AUTHOR), van der Horst-Bruinsma, IE² (AUTHOR), Nurmohamed, MT^1,2 (AUTHOR), Wolbink, G^1,3 (AUTHOR)

Publikováno v: Scandinavian Journal of Rheumatology. Mar2018, Vol. 47 Issue 2, p122-126. 5p. 1 Chart, 1 Graph.

Evaluation of dose-tapering strategies for intravenous tocilizumab in rheumatoid arthritis patients using model-based pharmacokinetic/pharmacodynamic simulations.

Autor: Bastida C; Pharmacy Department, Division of Medicines, Hospital Clinic Barcelona, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain. cbastida@clinic.cat.; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. cbastida@clinic.cat., Huitema ADR; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center, Utrecht University, Utrecht, The Netherlands., l'Ami MJ; Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands., Ruiz-Esquide V; Arthritis Unit, Rheumatology Department, Hospital Clinic Barcelona, Universitat de Barcelona, Barcelona, Spain., Wolbink GJ; Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands.; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Centre, Amsterdam, The Netherlands., Sanmartí R; Arthritis Unit, Rheumatology Department, Hospital Clinic Barcelona, Universitat de Barcelona, Barcelona, Spain., Soy D; Pharmacy Department, Division of Medicines, Hospital Clinic Barcelona, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain.; IDIBAPS, Barcelona, Spain.

Publikováno v: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2020 Oct; Vol. 76 (10), pp. 1417-1425. Date of Electronic Publication: 2020 Jun 09.

Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte et al .

Autor: l'Ami MJ; Rheumatology, Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, The Netherlands m.lami@reade.nl., Krieckaert CL; Rheumatology, Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, The Netherlands., Nurmohamed MT; Rheumatology, Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center | Amsterdam Medical Center, VU Medical Center, Amsterdam, The Netherlands., van Vollenhoven RF; Amsterdam Rheumatology and Immunology Center | Amsterdam Medical Center, VU Medical Center, Amsterdam, The Netherlands., Rispens T; Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands., Boers M; Amsterdam Rheumatology and Immunology Center | Amsterdam Medical Center, VU Medical Center, Amsterdam, The Netherlands.; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands., Wolbink GJ; Rheumatology, Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, The Netherlands.; Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Jul; Vol. 79 (7), pp. e82. Date of Electronic Publication: 2019 May 09.

A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial.

Autor: Seppen BF; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.; Department of Rheumatology, VU Medical Center, Amsterdam UMC, Amsterdam, Netherlands., L'ami MJ; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands., Duarte Dos Santos Rico S; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands., Ter Wee MM; Department of Epidemiology & Biostatistics, Amsterdam Public Health, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands., Turkstra F; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands., Roorda LD; Department of Rehabilitation, Reade, Amsterdam, Netherlands., Catarinella FS; Brightfish BV, Amsterdam, Netherlands., van Schaardenburg D; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.; Department of Rheumatology, Amsterdam Medical Center, Amsterdam UMC, Amsterdam, Netherlands., Nurmohamed MT; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.; Department of Rheumatology, VU Medical Center, Amsterdam UMC, Amsterdam, Netherlands., Boers M; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.; Department of Epidemiology & Biostatistics, Amsterdam Public Health, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands., Bos WH; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2020 Feb 19; Vol. 9 (2), pp. e15105. Date of Electronic Publication: 2020 Feb 19.